Mark S. deSouza - Concepedia

Author

Mark S. deSouza

Armed Forces Research Institute of Medical Science

Also Known As

M DeSouza, M deSouza, M. S. deSouza, Mark DeSouza, Mark S deSouza, Mark S. DeSouza, Mark S. deSouza, Mark deSouza

Publications

993

Citations

H-Index

Concepts

All Affiliations

Armed Forces Research Institute of Medical Science University of Washington Walter Reed Army Institute of Research Ministry of Public Health Mahidol University

About

Mark S. deSouza is an author at Armed Forces Research Institute of Medical Science specializing in medicine, hiv, and vaccination.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	543
2	Immunology	3	3	514
3	Health Sciences	1	1	29
4	Neurology	1	1	29
5	Neuroscience	1	1	29

Mark S. deSouza

Publications

955

Citations

H-Index

Page 1

	Year	Citations
Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env V2 Morgane Rolland, Paul T. Edlefsen, Brendan B. Larsen, Nature VaccinationViral EvolutionGenetic SignaturesVaccine TargetHuman Retrovirus	2012	420
Serum-mediated resolution of Lyme arthritis in mice. Stephen W. Barthold, Mark S. deSouza, Sunlian Feng PubMed	1996	88
A phase I/II trial of HIV SF2 gp120/MF59 vaccine in seronegative Thais Sorachai Nitayaphan, Chirasak Khamboonruang, Narongrid Sirisophana, Vaccine VaccinationVaccine DevelopmentImmunologySeronegative ThaisVaccine Efficacy	2000	66
Analysis of HLA A*02 Association with Vaccine Efficacy in the RV144 HIV-1 Vaccine Trial Andrew J. Gartland, Sue Li, John McNevin, Journal of Virology	2014	63
Cross‐Clade Cytotoxic T Cell Response to Human Immunodeficiency Virus Type 1 Proteins among HLA Disparate North Americans and Thais Mark S. deSouza, M D Robb, Lauri E. Markowitz, The Journal of Infectious Diseases	1998	61
Vaccine-induced Human Antibodies Specific for the Third Variable Region of HIV-1 gp120 Impose Immune Pressure on Infecting Viruses Susan Zolla‐Pazner, Paul T. Edlefsen, Morgane Rolland, EBioMedicine	2014	57
Comprehensive Screening for Human Immunodeficiency Virus Type 1 Subtype-Specific CD8 Cytotoxic T Lymphocytes and Definition of Degenerate Epitopes Restricted by HLA-A0207 and -C<sub>W</sub>0304 Alleles Jeffrey R. Currier, Mark S. deSouza, Penprapa Chanbancherd, Journal of Virology	2002	43
Purified, Soluble Recombinant Mouse Hepatitis Virus Receptor, Bgp1<sup>b</sup>, and Bgp2 Murine Coronavirus Receptors Differ in Mouse Hepatitis Virus Binding and Neutralizing Activities Bruce D. Zelus, David R. Wessner, Richard K. Williams, Journal of Virology	1998	35
Neuropsychological abnormalities in patients with dementia in CRF 01_AE HIV-1 infection Victor Valcour, Pasiri Sithinamsuwan, Samart Nidhinandana, Neurology NeuropsychologyNeuropsychological AbnormalitiesNeuropsychiatryAlzheimer's DiseaseNeurology	2007	29
Specific Antibody Responses to Vaccination with Bivalent CM235/SF2 gp120: Detection of Homologous and Heterologous Neutralizing Antibody to Subtype E (CRF01.AE) HIV Type 1 Jérôme H. Kim, Punnee Pitisuttithum, C Kamboonruang, AIDS Research and Human Retroviruses VaccinationSubtype EPrimary Isolate Cm235Cm235/dendritic CellVaccine Development	2003	28

Page 1